Within the genetic heterogeneity of CLL, disruptive mutations of the BCL6 co-repressor (BCOR) were found in up to 2% of cases [4] and have been included among the lymphoma driver genes [1]. This evidence concerns the gene BCOR and B-cell chronic lymphocytic leukemia.